(Q34621390)

3 August 2017

title

Plasma enalapril levels and hormonal effects after short- and long-term administration in essential hypertension (English)

1 reference

3 August 2017

main subject

essential hypertension

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1984.TB02602.X

5 August 2023

1

C. I. Johnston

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6099738

5 August 2023

author name string

B. J. Jackson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6099738

5 August 2023

I. Larmour

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6099738

5 August 2023

R. Cubella

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6099738

5 August 2023

D. Casley

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6099738

5 August 2023

language of work or name

English

0 references

publication date

1 January 1984

1 reference

full work available at URL

3 August 2017

https://europepmc.org/articles/PMC1463475

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6099738

https://europepmc.org/articles/PMC1463475?pdf=render

5 August 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6099738

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2125.1984.tb02602.x

5 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1984.TB02602.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1984.tb02602.x/fullpdf

5 August 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1984.TB02602.X

British Journal of Clinical Pharmacology

5 August 2023

published in

1 reference

3 August 2017

volume

18 Suppl 2

1 reference

3 August 2017

page(s)

233S-239S, 241S

1 reference

Medical intelligence drug therapy: captopril

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463475

Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463475

Enalapril maleate and a lysine analogue (MK-521): disposition in man

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463475

Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463475

Enzymes of the Renin-Angiotensin System and their Inhibitors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463475

A new class of angiotensin-converting enzyme inhibitors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463475

The physiological disposition and metabolism of enalapril maleate in laboratory animals

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463475

Effect of converting enzyme inhibition by enalapril on sodium homeostasis in the rat.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463475

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463475

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463475

Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1463475

RISE IN PLASMA CONCENTRATION OF ALDOSTERONE DURING LONG-TERM ANGIOTENSIN II SUPPRESSION

7 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1984.TB02602.X

Clinical use of an orally acting converting enzyme inhibitor: captopril

21 January 2018

1 reference

12 December 2020

Captopril compared with other antirenin system agents in hypertensive patients: its triphasic effects on blood pressure and its use to identify and treat the renin factor

1 reference

12 December 2020

Three new long-acting converting-enzyme inhibitors: Relationship between plasma converting-enzyme activity and response to angiotensin I

1 reference

12 December 2020

Acute effects of captopril on blood pressure and circulating hormone levels in salt-replete and depleted normal subjects and essential hypertensive patients

1 reference

12 December 2020

ANTIHYPERTENSIVE EFFECT OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME INHIBITOR "MK-421"

1 reference

12 December 2020

Treatment of hypertension with angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Converting enzyme inhibition: implications for renal perfusion and function

1 reference

12 December 2020

Correlation between angiotensin converting enzyme inhibition and the acute hypotensive response to MK 421 in essential hypertension

1 reference

12 December 2020

Antihypertensive therapy with MK 421: angiotensin II--renin relationships to evaluate efficacy of converting enzyme blockade

1 reference

12 December 2020

Mechanism for hypotensive action of angiotensin converting enzyme inhibitors

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitors in the treatment of hypertension

1 reference

12 December 2020

Long-term clinical experience with enalapril in essential hypertension

1 reference

12 December 2020

Enalapril and autonomic reflexes and exercise performance

1 reference

12 December 2020

The effects of converting enzyme inhibitors on plasma angiotensinogen and plasma aldosterone in sodium-depleted rats

1 reference

12 December 2020

Relationship of antihypertensive effect of enalapril to serum MK-422 levels and angiotensin converting enzyme inhibition

1 reference

12 December 2020

Antihypertensive Therapy with MK 4211

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2125.1984.TB02602.X

5 August 2023

Identifiers

1 reference

3 August 2017

1 reference

3 August 2017

1 reference